Details

Name: Rexahn Pharmaceuticals, Inc

Email: info@rexahn.com

Phone: 2402685300

Address: 15245 Shady Grove Road Suite 455 Rockville, MD 20850

Stock Symbol: REXN

News

Rexahn pharmaceuticals, inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of cancer. the company's product pipeline include rx-3117, which is in phase iia clinical trials for the treatment of patients with relapsed or refractory metastatic pancreatic cancer, as well as bladder, colon, lung and cervical cancer; and rx-5902 that is in phase iia clinical trials to treat patients with metastatic triple negative breast cancer. it is also developing rx-0301, which is in preclinical development stage for the treatment of hepatocellular carcinoma. the company has collaboration agreements with zhejiang haichang biotechnology co., ltd.; merck sharp & dohme b.v.; and biosense global llc. rexahn pharmaceuticals, inc. is headquartered in rockville, maryland.